NuvOx Therapeutics Overview
- Year Founded
-
2008
- Status
-
IPO Registration
- Employees
-
9
- Latest Deal Type
-
IPO
- (Announced)
- Latest Deal Amount
-
$20M
- Investors
-
19
NuvOx Therapeutics General Information
Description
NuvOx Therapeutics Inc a clinical-stage biopharmaceutical company developing oxygen therapeutic solutions for the treatment of diseases where hypoxia, or lack of oxygen, plays a critical role. Its flagship product candidate, NanO2, is an intravenous emulsion containing dodecafluoropentane as the active pharmaceutical ingredient (API).
Contact Information
Website
www.nuvoxtherapeutics.comCorporate Office
- 1635 East 18th Street
- Tucson, AZ 85719
- United States
Corporate Office
- 1635 East 18th Street
- Tucson, AZ 85719
- United States
NuvOx Therapeutics Timeline
NuvOx Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 20. IPO | 17-Jul-2026 | $20M | Announced | Generating Revenue/Not Profitable | ||
| 19. Mezzanine | 22-Nov-2024 | Completed | Clinical Trials - Phase 2 | |||
| 18. Later Stage VC (Series B) | 01-Apr-2024 | Completed | Clinical Trials - Phase 2 | |||
| 17. Grant | 24-Apr-2023 | Completed | Clinical Trials - Phase 2 | |||
| 16. Later Stage VC | 01-Jan-2023 | Completed | Clinical Trials - Phase 2 | |||
| 15. Grant | 15-Sep-2021 | Completed | Clinical Trials - Phase 2 | |||
| 14. Debt - PPP | 01-May-2020 | Completed | Clinical Trials - Phase 2 | |||
| 13. Grant | 15-Jul-2018 | Completed | Clinical Trials - Phase 2 | |||
| 12. Grant | 29-Sep-2017 | $3M | $7.36M | Completed | Clinical Trials - Phase 2 | |
| 11. Later Stage VC | 01-Sep-2017 | $3M | $7.36M | Completed | Clinical Trials - Phase 2 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
NuvOx Therapeutics Comparisons
Industry
Financing
Details
NuvOx Therapeutics Competitors (59)
One of NuvOx Therapeutics’s 59 competitors is BioMarin Pharmaceutical, a Formerly PE-Backed company based in San Rafael, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioMarin Pharmaceutical | Formerly PE-Backed | San Rafael, CA | ||||
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
| Apellis Pharmaceuticals | Formerly VC-backed | Waltham, MA | ||||
| Crinetics Pharmaceuticals | Formerly VC-backed | San Diego, CA | ||||
| Abeona Therapeutics | Corporation | Cleveland, OH |
NuvOx Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NuvOx Therapeutics Patents
NuvOx Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240277627-A1 | Novel fluorochemical cardiac resuscitation | Pending | 22-Feb-2023 | ||
| US-20240207199-A1 | Fluorocarbon compositions and methods for enhancing immunotherapy | Inactive | 30-Apr-2021 | ||
| WO-2022232652-A1 | Fluorocarbon compositions and methods for enhancing immunotherapy | Inactive | 30-Apr-2021 | ||
| WO-2021216402-A1 | Methods and compositions for treating viral infections and respiratory distress | Inactive | 20-Apr-2020 | ||
| US-20190365665-A1 | Iso-osmotic and near iso-osmotic oxygen therapeutic formulations and methods thereof | Inactive | 24-Jan-2017 | A61P7/06 |
NuvOx Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NuvOx Therapeutics Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Westlake Ventures (Saint Petersburg) | Venture Capital | Minority | ||
| Band of Angels | Angel Group | Minority | ||
| K2X | Venture Capital | Minority | ||
| Keiretsu Capital | Venture Capital | Minority | ||
| MEDA Angels | Angel Group | Minority |
NuvOx Therapeutics FAQs
-
When was NuvOx Therapeutics founded?
NuvOx Therapeutics was founded in 2008.
-
Where is NuvOx Therapeutics headquartered?
NuvOx Therapeutics is headquartered in Tucson, AZ.
-
What is the size of NuvOx Therapeutics?
NuvOx Therapeutics has 9 total employees.
-
What industry is NuvOx Therapeutics in?
NuvOx Therapeutics’s primary industry is Drug Discovery.
-
Is NuvOx Therapeutics a private or public company?
NuvOx Therapeutics is a Private company.
-
What is the current valuation of NuvOx Therapeutics?
The current valuation of NuvOx Therapeutics is .
-
What is NuvOx Therapeutics’s current revenue?
The current revenue for NuvOx Therapeutics is .
-
How much funding has NuvOx Therapeutics raised over time?
NuvOx Therapeutics has raised $19.8M.
-
Who are NuvOx Therapeutics’s investors?
Westlake Ventures (Saint Petersburg), Band of Angels, K2X, Keiretsu Capital, and MEDA Angels are 5 of 19 investors who have invested in NuvOx Therapeutics.
-
Who are NuvOx Therapeutics’s competitors?
BioMarin Pharmaceutical, Intas Pharmaceuticals, Apellis Pharmaceuticals, Crinetics Pharmaceuticals, and Abeona Therapeutics are some of the 59 competitors of NuvOx Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
